Occult hepatitis B infection in blood donors from South East Asia: Molecular characterisation and potential mechanisms of occurrence

Gut

Volumn 61, Issue 12, 2012, Pages 1744-1753

  Candotti, Daniel ^a,b   Lin, C Kit ^c   Belkhiri, Dalila ^b   Sakuldamrongpanich, Tasanee ^d   Biswas, Subhajit ^b   Lin, Sujen ^e   Teo, Diana ^f   Ayob, Yasmin ^g   Allain, Jean Pierre ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b Cambridge Blood Centre   (United Kingdom)

^c Hong Kong Red Cross Blood Transfusion Centre   (Hong Kong)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e Taiwan Blood Services Foundation   (Taiwan)

^f HEALTH SCIENCES AUTHORITY   (Singapore)

^g National Blood Centre   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RNA SPLICING; SOUTHEAST ASIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ADOLESCENT; ADULT; ASIA, SOUTHEASTERN; ASYMPTOMATIC INFECTIONS; BIOLOGICAL MARKERS; BLOOD DONORS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA SPLICING; VIRAL LOAD; YOUNG ADULT;

EID: 84868676890     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301281     Document Type: Article

References (31)

1. Raimondo R, Allain J-P, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652-7.
2. Allain J-P, Belkhiri D, Vermeulen M, et al. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009;49:1868-76.
3. Candotti D, Grabarczyk P, Ghiazza P, et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008;49:537-47.
4. Zheng X, Ye X, Zhang L, et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 2011;49:1730-7.
5. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006;(36 Suppl 1):S33-44.
6. Nantachit N, Thaikruea L, Thongsawat S, et al. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007;47:1803-8. (Pubitemid 47438545)
7. Yang MH, Li L, Hung YS, et al. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus dNA in Taiwan. Transfusion 2010;50:65-74.
8. Yuan Q, Ou SH, Chen CR, et al. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010;48:357-62.
9. Yuen MF, Wong DK, Lee CK, et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis 2011;52:624-32.
10. Li L, Chen PJ, Chen MH, et al. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C. Transfusion 2008;48:1198-206. (Pubitemid 351793490)
11. Phikulsod S, Oota S, Tirawatnapong T, et al. One-year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009;49:1126-35.
12. El Chaar M, Candotti D, Crowther RA, et al. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 2010;52:1600-10.
13. Katsoulidou A, Paraskevis D, Magiorkinis E, et al. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 2009;81:815-25.
14. Chaudhuri V, Tayal R, Nayak B, et al. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004;127:1356-71. (Pubitemid 39457762)
15. Fang Y, Teng X, Xu WZ, et al. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol 2009;81:826-35.
16. Sengupta S, Rehman S, Durgapal H, et al. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol 2007;79:220-8. (Pubitemid 46213185)
17. Pollicino T, Raffa G, Costantino L, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007;45:277-85. (Pubitemid 46374584)
18. Hass M, Hannoun C, Kalinina T, et al. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005;42:93-103. (Pubitemid 40911316)
19. Lee JK, Shim JH, Lee HC, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian population with normal liver histology. Hepatology 2010;51:1577-83.
20. Günther S, Sommer G, Von Breunig F, et al. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 1998;36:531-8. (Pubitemid 28060325)
21. Bremer CM, Saniewski M, Wend UC, et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009;49:1621-9.
22. Louisirirotchanakul S, Oota S, Khuponsarb K, et al. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40.
23. Inaba S, Ito A, Miyata Y, et al. Individual nucleic amplification technology does not prevent all hepatits B virus transmission by blood transfusion. Transfusion 2006;46:2028-9. (Pubitemid 44631612)
24. Dreier J, Kröger M, Diekmann J, et al. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004;14:97-103. (Pubitemid 38623072)
25. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, et al. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008;48:1022-5.
26. Manzini P, Abate ML, Valpreda C, et al. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009;49:757-64.
27. Vivekanandan P, Kannangai R, Ray SC, et al. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 2008;46:1227-36. (Pubitemid 351589907)
28. Chen CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002;122:1756-62. (Pubitemid 34651418)
29. Salisse J, Sureau C. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol 2009;83:9321-8.
30. Sommer G, Heise T. Posttranscriptional control of HBV gene expression. Front Biosci 2008;13:5533-47.
31. Buratti E, Baralle FE. Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 2004;24:10505-14. (Pubitemid 39603113)